Recent technological developments now permit SAR aircraft, helicopters and drones to take thousands of image-recognition images during current active SAR missions, greatly improving the mission's target detection rates.
The idea is to mount a novel low-cost, lightweight and miniature acoustomicrofluidic nebulisation platform onto an unmanned aerial vehicle or miniature autonomous robotic vehicle to autonomously and remotely deliver therapeutics and antidotes via inhalation to incapacitated subjects exposed to hazardous threats rapidly.
There is a challenge for Collaboration between ANA lifesaving stakeholders to increase the numbers, and sharing, of helicopters to provide adequate coverage
